Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

114.94
Delayed Data
As of 3:59pm ET
 +3.05 / +2.73%
Today’s Change
110.56
Today|||52-Week Range
208.88
-39.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues604.6M637.1M700.9M678.2M
 
 
 
 
 
Cost of Goods Sold45.1M45.7M43.8M59.0M
 
 
 
 
 
Depreciation And Amortization12.6M49.7M93.8M96.8M
 
 
 
 
 
 
Operating ExpensesGross Income547.0M541.7M563.3M522.5M
 
 
 
 
 
General Expenses347.5M373.5M432.6M392.2M
 
 
 
 
 
Research And Development126.1M161.0M191.0M176.3M
 
 
 
 
 
Total Operating Expenses405.1M468.8M570.2M547.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income199.5M168.3M130.7M130.3M
 
 
 
 
 
Extraordinary Credit0.000.000.0014.8M
 
 
Extraordinary Charge-50.0M-43.2M-33.3M-2.1M
 
 
 
 
 
Interest Expense On Debt4.0M20.0M23.2M23.9M
 
 
 
 
 
Other Expenses29.6M32.3M-1.1M22.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income177.3M139.4M74.5M143.6M
 
 
 
 
 
Income Taxes-7.1M-323.1M-7.9M-51.4M
 
 
 
 
 
Net Income170.2M-183.8M66.6M92.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS202.2M226.2M225.5M225.1M
 
 
 
 
 
Shares To Calculate EPS Diluted204.5M226.2M228.0M226.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.83-$0.81$0.29$0.41
 
 
 
 
 
EPS Diluted$0.83-$0.81$0.29$0.41